CANDEL THERAPEUTICS INCCADL

Neutral

ASignal's systematic analysis rates CADL as Neutral.

Reflects the latest available analysis · analyzed Sep 20, 2026

The case on CADL

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Strong cash position with $201.56M cash and low debt ($49.52M), resulting in a healthy debt-to-equity ratio of 0.39x
  • High liquidity with current ratio of 16.09x and quick ratio of 15.89x, indicating strong short-term financial health
  • Price near lower Bollinger Band (10.18) and RSI of 26.43 suggests potential oversold rebound
  • Positive free cash flow trend relative to market cap, despite negative absolute value
VS
Bear case
  • Negative MACD histogram (-0.283) and MACD below signal line indicate ongoing downtrend
  • Negative price momentum (-0.151) and price below SMA20 and SMA50 confirm technical weakness
  • Negative return on equity (-81.84%) and negative return on assets (-28.64%) reflect poor capital efficiency
  • Zero operating, net, and gross margins indicate lack of profitability
  • No Reddit mentions, suggesting low retail investor interest or visibility
  • Forward P/E of -17.36x and negative EV/EBITDA (-9.51x) reflect unprofitable earnings base
Subscriber-only

See the full verdict on CADL

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes CADL

Most investors never get a second opinion, let alone several. ASignal runs CADL past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

CANDEL THERAPEUTICS INC (CADL) Stock Analysis - ASignal rates it Neutral